MXCT
Income statement / Annual
Last year (2023), MaxCyte, Inc.'s total revenue was $41.29 M,
a decrease of 6.72% from the previous year.
In 2023, MaxCyte, Inc.'s net income was -$37.92 M.
See MaxCyte, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$41.29 M
|
$44.26 M
|
$33.89 M
|
$26.17 M
|
$21.62 M
|
$16.67 M
|
$13.99 M
|
$12.27 M
|
$9.29 M
|
$7.16 M
|
| Cost of Revenue |
$4.74 M |
$5.10 M |
$3.65 M |
$2.77 M |
$2.50 M |
$1.84 M |
$1.45 M |
$1.31 M |
$1.03 M |
$957,500.00 |
| Gross Profit |
$36.55 M |
$39.16 M |
$30.25 M |
$23.40 M |
$19.12 M |
$14.83 M |
$12.53 M |
$10.96 M |
$8.26 M |
$6.21 M |
| Gross Profit Ratio |
0.89 |
0.88 |
0.89 |
0.89 |
0.88 |
0.89 |
0.9 |
0.89 |
0.89 |
0.87 |
| Research and Development
Expenses |
$23.82 M
|
$19.51 M
|
$15.41 M
|
$17.74 M
|
$17.60 M
|
$11.24 M
|
$11.28 M
|
$4.70 M
|
$3.01 M
|
$2.49 M
|
| General & Administrative
Expenses |
$30.07 M
|
$25.83 M
|
$18.68 M
|
$8.39 M
|
$6.09 M
|
$5.28 M
|
$4.52 M
|
$4.20 M
|
$2.67 M
|
$2.47 M
|
| Selling & Marketing
Expenses |
$26.98 M
|
$18.65 M
|
$13.00 M
|
$8.33 M
|
$7.85 M
|
$6.72 M
|
$6.02 M
|
$4.78 M
|
$3.34 M
|
$2.52 M
|
| Selling, General &
Administrative Expenses |
$57.04 M
|
$44.48 M
|
$31.68 M
|
$16.71 M
|
$13.94 M
|
$12.01 M
|
$10.54 M
|
$8.99 M
|
$6.01 M
|
$4.99 M
|
| Other Expenses |
$3.99 M |
$2.53 M |
$1.35 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$15,700.00 |
$20,000.00 |
$0.00 |
| Operating Expenses |
$84.85 M |
$66.52 M |
$48.44 M |
$34.46 M |
$31.54 M |
$23.25 M |
$21.82 M |
$13.69 M |
$9.02 M |
$7.48 M |
| Cost And Expenses |
$89.59 M |
$71.62 M |
$52.08 M |
$37.23 M |
$34.04 M |
$25.09 M |
$23.28 M |
$14.99 M |
$10.05 M |
$8.44 M |
| Interest Income |
$10.38 M |
$3.92 M |
$150,800.00 |
$65,900.00 |
$206,100.00 |
$170,300.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$126,900.00 |
$1.04 M |
$825,600.00 |
$681,100.00 |
$614,600.00 |
$625,300.00 |
$637,800.00 |
$704,400.00 |
$561,300.00 |
| Depreciation &
Amortization |
$4.17 M
|
$2.70 M
|
$1.42 M
|
$1.05 M
|
$613,500.00
|
$344,000.00
|
$142,900.00
|
$105,700.00
|
$93,300.00
|
$92,000.00
|
| EBITDA |
-$44.13 M
|
-$20.87 M
|
-$16.76 M
|
-$9.94 M
|
-$11.60 M
|
-$7.91 M
|
-$9.15 M
|
-$2.60 M
|
-$647,800.00
|
-$1.18 M
|
| EBITDA Ratio |
-1.07 |
-0.47 |
-0.49 |
-0.38 |
-0.54 |
-0.47 |
-0.65 |
-0.21 |
-0.07 |
-0.17 |
| Operating Income Ratio
|
-1.17
|
-0.62
|
-0.54
|
-0.42
|
-0.57
|
-0.51
|
-0.66
|
-0.22
|
-0.08
|
-0.18
|
| Total Other
Income/Expenses Net |
$10.38 M
|
$3.79 M
|
-$893,600.00
|
-$759,700.00
|
-$475,000.00
|
-$444,300.00
|
-$625,300.00
|
-$622,100.00
|
-$684,400.00
|
-$561,300.00
|
| Income Before Tax |
-$37.92 M |
-$23.57 M |
-$19.08 M |
-$11.82 M |
-$12.90 M |
-$8.87 M |
-$9.92 M |
-$3.35 M |
-$1.45 M |
-$1.84 M |
| Income Before Tax Ratio
|
-0.92
|
-0.53
|
-0.56
|
-0.45
|
-0.6
|
-0.53
|
-0.71
|
-0.27
|
-0.16
|
-0.26
|
| Income Tax Expense |
$0.00 |
-$3.79 M |
$1.04 M |
$825,600.00 |
$681,100.00 |
$170,300.00 |
$0.00 |
$653,500.00 |
$724,400.00 |
$0.00 |
| Net Income |
-$37.92 M |
-$19.78 M |
-$20.13 M |
-$12.64 M |
-$13.58 M |
-$8.87 M |
-$9.92 M |
-$3.35 M |
-$1.45 M |
-$1.84 M |
| Net Income Ratio |
-0.92 |
-0.45 |
-0.59 |
-0.48 |
-0.63 |
-0.53 |
-0.71 |
-0.27 |
-0.16 |
-0.26 |
| EPS |
-0.37 |
-0.19 |
-0.22 |
-0.18 |
-0.24 |
-0.17 |
-0.2 |
-0.0998 |
-0.0333 |
-0.0423 |
| EPS Diluted |
-0.37 |
-0.19 |
-0.22 |
-0.18 |
-0.24 |
-0.17 |
-0.2 |
-0.0998 |
-0.0333 |
-0.0423 |
| Weighted Average Shares
Out |
$103.27 M
|
$101.70 M
|
$90.62 M
|
$69.46 M
|
$56.40 M
|
$51.18 M
|
$48.64 M
|
$33.52 M
|
$43.47 M
|
$43.47 M
|
| Weighted Average Shares
Out Diluted |
$103.27 M
|
$101.70 M
|
$90.62 M
|
$69.46 M
|
$56.40 M
|
$51.18 M
|
$48.64 M
|
$33.52 M
|
$43.47 M
|
$43.47 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
